Immune Checkpoint Inhibitor Therapy as a Novel and Effective Therapy for Aggressive Cutaneous Squamous Cell Carcinoma

被引：0
|
作者：
Beasley, G. [2 ]
Kurtz, J. [1 ]
Howard, J. H. [2 ]
Terando, A. [2 ]
Agnese, D. [2 ]
David, L. [2 ]
Olencki, T. [2 ]
机构：
[1] Doctors Hosp, Columbus, OH USA
[2] Ohio State Univ, Columbus, OH 43210 USA
来源：
ANNALS OF SURGICAL ONCOLOGY | 2017年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
88
引用
收藏
页码：S37 / S37
页数：1
相关论文
共 50 条
  • [21] Adjuvant therapy in renal cell carcinoma: Tyrosine kinase inhibitor versus immune checkpoint inhibitor
    Zhou, Qingbo
    Liu, Jianjiang
    Xie, Shaoqin
    MEDICINE, 2024, 103 (22) : E38329
  • [22] Gene mutation analysis and immune checkpoint therapy in head and neck squamous cell carcinoma
    Hua Yang
    Yuxue Wei
    Gangli Liu
    Oncology and Translational Medicine, 2022, 8 (01) : 36 - 42
  • [23] The prospect of combination therapy with immune checkpoint inhibitors and chemotherapy for squamous cell carcinoma of the lung
    Ichiki, Yoshinobu
    Fukuyama, Takashi
    Nakanishi, Kozo
    TRANSLATIONAL LUNG CANCER RESEARCH, 2020, 9 (03) : 811 - 815
  • [24] Cutaneous toxicities in lung cancer patients on immune checkpoint inhibitor therapy
    Keiser, Monika
    Patel, Anisha B.
    Altan, Mehmet
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2020, 83 (06) : AB75 - AB75
  • [25] Cutaneous Toxicities in Lung Cancer Patients on Immune Checkpoint Inhibitor Therapy
    Keiser, Monika F.
    Patel, Anisha B.
    Altan, Mehmet
    CLINICAL LUNG CANCER, 2021, 22 (03) : 195 - +
  • [26] Aggressive cutaneous squamous cell carcinoma associated with prolonged voriconazole therapy in a renal transplant patient
    Vanacker, A.
    Fabre, G.
    Van Dorpe, J.
    Peetermans, W. E.
    Maes, B.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2008, 8 (04) : 877 - 880
  • [27] AGGRESSIVE CUTANEOUS SQUAMOUS CELL CARCINOMA ASSOCIATED WITH PROLONGED VORICONAZOLE THERAPY IN A RENAL TRANSPLANT PATIENT
    Vanacker, A.
    Fabre, G.
    Vandorpe, J.
    Peetermans, W. E.
    Maes, B.
    ACTA CLINICA BELGICA, 2009, 64 (02) : 175 - 175
  • [28] Current Landscape of Immune Checkpoint Inhibitor Therapy for Hepatocellular Carcinoma
    Ruff, Samantha M.
    Manne, Ashish
    Cloyd, Jordan M.
    Dillhoff, Mary
    Ejaz, Aslam
    Pawlik, Timothy M.
    CURRENT ONCOLOGY, 2023, 30 (06) : 5863 - 5875
  • [29] Current Landscape of Immune Checkpoint Inhibitor Therapy for Hepatocellular Carcinoma
    Machairas, Nikolaos
    Tsilimigras, Diamantis, I
    Pawlik, Timothy M.
    CANCERS, 2022, 14 (08)
  • [30] Factors influencing the development of cutaneous squamous cell carcinoma in patients on BRAF inhibitor therapy
    Anforth, Rachael
    Menzies, Alexander
    Byth, Karen
    Carlos, Giuliana
    Chou, Shaun
    Sharma, Raghwa
    Scolyer, Richard A.
    Kefford, Richard
    Long, Georgina V.
    Fernandez-Penas, Pablo
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2015, 72 (05) : 809 - +
12345